Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients
The Olanzapine Regimen will be superior to the Standard Regimen, as measured by the proportion of patients with Complete Response in the 120 hours following AC chemotherapy.
Breast Cancer
DRUG: Experimental drug: Aprepitant|DRUG: Experimental drug: Ondansetron|DRUG: Experimental drug: Dexamethasone|DRUG: Experimental drug: Olanzapine|DRUG: Standard: Aprepitant|DRUG: Standard: Ondansetron|DRUG: Standard: Dexamethasone
Number of episodes of nausea in the first 120 hours after first cycle of chemotherapy., Number of episodes of nausea in the first 120 hours after first cycle of chemotherapy., 120 hours|Number of episodes of vomiting in the first 120 hours after first cycle of chemotherapy., Number of episodes of vomiting in the first 120 hours after first cycle of chemotherapy., 120 hours
Number of episodes of nausea in the first 120 hours during 4 cycles of chemotherapy., Number of episodes of nausea in the first 120 hours during 4 cycles of chemotherapy., 120 hours|Number of episodes of vomiting in the first 120 hours during 4 cycles of chemotherapy., Number of episodes of vomiting in the first 120 hours during 4 cycles of chemotherapy., 120 hours
The Olanzapine Regimen will be superior to the Standard Regimen, as measured by the proportion of patients with Complete Response in the 120 hours following AC chemotherapy.